- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
4 result(s) found for: Electron microscope.
Displaying page 1 of 1.
EudraCT Number: 2016-000783-42 | Sponsor Protocol Number: SDX-PL/001/2016 | Start Date*: 2016-09-19 | |||||||||||
Sponsor Name:Alfa Wassermann Polska Sp. z o.o. | |||||||||||||
Full Title: A phase 3, prospective, open, pilot, monocentric study to evaluate the effect of sulodexide administered at registered dose on morphology and functional properties of the venous endothelium in pati... | |||||||||||||
Medical condition: chronic venous insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000385-38 | Sponsor Protocol Number: BEL116472 | Start Date*: 2012-05-18 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Ltd | |||||||||||||
Full Title: BEL116472. A 2 year mechanistic study of belimumab in Idiopathic Membranous Glomerulonephropathy | |||||||||||||
Medical condition: Idiopathic Membranous Glomerulonephropathy (IMGN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000242-38 | Sponsor Protocol Number: BEL114674 | Start Date*: 2013-01-09 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: BEL114674: A 2 year study of efficacy and safety of intravenous belimumab versus placebo in subjects with idiopathic membranous nephropathy | |||||||||||||
Medical condition: Idiopathic Membranous Nephropathy (IMN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) ES (Prematurely Ended) CZ (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004271-14 | Sponsor Protocol Number: DAPAS | Start Date*: 2021-12-06 | |||||||||||
Sponsor Name:Aarhus University Hospital, department of Cardiology | |||||||||||||
Full Title: Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis intervention | |||||||||||||
Medical condition: Patients with aortic stenosis undergoing trans catheter aortic valve replacement. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
